GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
13 Nov 2013 05:28 PM
RNS
Transaction in Own Shares
12 Nov 2013 03:52 PM
RNS
Director/PDMR Shareholding
12 Nov 2013 03:51 PM
RNS
Director/PDMR Shareholding
12 Nov 2013 07:01 AM
RNS
darapladib Phase III Study Results
11 Nov 2013 05:06 PM
RNS
Director/PDMR Shareholding
01 Nov 2013 05:29 PM
RNS
Transaction in Own Shares
01 Nov 2013 12:46 PM
RNS
Total Voting Rights
31 Oct 2013 05:17 PM
RNS
Transaction in Own Shares
30 Oct 2013 05:30 PM
RNS
Transaction in Own Shares
28 Oct 2013 05:38 PM
RNS
Transaction in Own Shares
28 Oct 2013 03:42 PM
RNS
Director/PDMR Shareholding
25 Oct 2013 05:07 PM
RNS
Transaction in Own Shares
25 Oct 2013 03:03 PM
RNS
Director/PDMR Shareholding
25 Oct 2013 01:00 PM
RNS
Dolutegravir Trii - EU Regulatory Submission
23 Oct 2013 12:00 PM
RNS
3rd Quarter Results
22 Oct 2013 05:17 PM
RNS
US FDA submission for Tivicay combination
22 Oct 2013 04:47 PM
RNS
Transaction in Own Shares
21 Oct 2013 04:54 PM
RNS
Transaction in Own Shares
18 Oct 2013 04:56 PM
RNS
Transaction in Own Shares
17 Oct 2013 04:49 PM
RNS
Transaction in Own Shares
16 Oct 2013 04:48 PM
RNS
Transaction in Own Shares
15 Oct 2013 05:03 PM
RNS
Transaction in Own Shares
15 Oct 2013 02:01 PM
RNS
Additional Listing
14 Oct 2013 04:54 PM
RNS
Transaction in Own Shares
14 Oct 2013 03:49 PM
RNS
Director/PDMR Shareholding
14 Oct 2013 12:28 PM
RNS
Director/PDMR Shareholding
11 Oct 2013 04:50 PM
RNS
Board Committee changes
11 Oct 2013 04:50 PM
RNS
Transaction in Own Shares
11 Oct 2013 04:16 PM
RNS
Director/PDMR Shareholding
11 Oct 2013 03:36 PM
RNS
Director/PDMR Shareholding
10 Oct 2013 04:54 PM
RNS
Transaction in Own Shares
10 Oct 2013 03:15 PM
RNS
Director/PDMR Shareholding
10 Oct 2013 03:14 PM
RNS
Director/PDMR Shareholding
10 Oct 2013 02:45 PM
RNS
Director/PDMR Shareholding
10 Oct 2013 02:43 PM
RNS
Director/PDMR Shareholding
10 Oct 2013 02:42 PM
RNS
Director/PDMR Shareholding
10 Oct 2013 02:41 PM
RNS
Director/PDMR Shareholding
09 Oct 2013 04:50 PM
RNS
Transaction in Own Shares
09 Oct 2013 12:07 PM
RNS
Director/PDMR Shareholding
09 Oct 2013 12:04 PM
RNS
Director/PDMR Shareholding
09 Oct 2013 12:03 PM
RNS
Director/PDMR Shareholding
08 Oct 2013 04:58 PM
RNS
Transaction in Own Shares
08 Oct 2013 02:31 PM
RNS
Director/PDMR Shareholding
07 Oct 2013 05:15 PM
RNS
Director/PDMR Shareholding
07 Oct 2013 04:53 PM
RNS
Transaction in Own Shares
04 Oct 2013 05:23 PM
RNS
Transaction in Own Shares
04 Oct 2013 03:32 PM
RNS
Director/PDMR Shareholding
04 Oct 2013 03:31 PM
RNS
Director/PDMR Shareholding
04 Oct 2013 03:29 PM
RNS
Director/PDMR Shareholding
03 Oct 2013 04:54 PM
RNS
Transaction in Own Shares

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings